Neuronal instability: implications for Rett's syndrome

被引:31
|
作者
Azmitia, EC
机构
[1] NYU, Dept Biol, New York, NY 10003 USA
[2] NYU, Dept Psychiat, New York, NY 10003 USA
[3] NYU, Ctr Neural Sci, New York, NY 10003 USA
来源
BRAIN & DEVELOPMENT | 2001年 / 23卷
关键词
serotonin; 5-HT1A; MAP-2; regression; BDNF; S-100; cytoskeleton; apoptosis; petal alcohol syndrome; cocaine; autism;
D O I
10.1016/S0387-7604(01)00368-0
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The maturational changes in the brain and spinal cord do not linearly proceed from immature in infants to mature in adults. Dendrites dynamically extend or retract as neurotrophic factors fluctuate. In certain cases mature neurons can be seen soon after birth, and in other cases immature neurons can be identified in the aged brain. Monoamine 'neurotransmitter'; such as serotonin (5-HT), dopamine and norepinephrine appear to function as Maintenance Growth Factors since they must be present in order to produce their maturational actions. Serotonin neurons contain TRK-B receptors and are sensitive to availability of the trophic factor, BDNF. 5-HT also functions by promoting the release of the glial extension factor, S-100beta. 5-HT and S-100beta can provide maturational signals to a variety of neurons, in both cortical and subcortical areas, and appear to be involved in regulating the maturation and release of acetylcholine and dopamine. We have shown that activation of the 5-HT1A receptor is particularly effective in inducing growth of stunted neurons. The mechanism of action of the 5-HT1A receptor involves both a direct inhibition on c-AMP and pCREB formation in postsynaptic neurons and a release of S-100beta from glial cells. Both these events are capable of stabilization and elaboration of the cytoskeleton of the neuron and inhibition of apoptosis. 5-HT1A receptors have been shown to effectively reverse stunted neurons and microencephaly produced,in animal models of fetal alcohol syndrome and prenatal cocaine administration. I discuss the implications for regressive disorders such as Rett's syndrome and autism, and the feasibility of treatments with 5-HT1A agonists in children with developmental disorders. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:S1 / S10
页数:10
相关论文
共 50 条
  • [1] Rett's syndrome:: Pathophysiology and anaesthesiological implications
    Häuser, FM
    Lukasewitz, P
    Wichert, A
    Lennartz, H
    ANASTHESIOLOGIE INTENSIVMEDIZIN NOTFALLMEDIZIN SCHMERZTHERAPIE, 1999, 34 (09): : 582 - 587
  • [2] Rett syndrome and neuronal development
    Johnston, MV
    Blue, ME
    Naidu, S
    JOURNAL OF CHILD NEUROLOGY, 2005, 20 (09) : 759 - 763
  • [3] Cyclooxygenase and brain development: Implications in Rett's syndrome
    Stamu, C
    Ho, L
    Willis, F
    Pasinetti, GM
    BIOLOGICAL PSYCHIATRY, 2000, 47 (08) : 136S - 136S
  • [4] Olfactory biopsies demonstrate a defect in neuronal development in Rett's syndrome
    Ronnett, GV
    Leopold, D
    Cai, XH
    Hoffbuhr, KC
    Moses, L
    Hoffman, EP
    Naidu, S
    ANNALS OF NEUROLOGY, 2003, 54 (02) : 206 - 218
  • [5] Rett's syndrome
    Schwartzman, Jos Salomao
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2007, 65 (2B) : 544 - 544
  • [6] Screening of chromosomal instability and inheritance of Rett syndrome
    Zubair, Mohamed
    Mohan, Gomathi
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 455
  • [7] Rett's syndrome
    Ferrer, Elisa
    Moral, Ma Angels
    DRUGS OF THE FUTURE, 2007, 32 (02) : 179 - 186
  • [8] GENETIC-IMPLICATIONS OF RETT SYNDROME
    WAHLSTROM, J
    BRAIN & DEVELOPMENT, 1985, 7 (06): : 573 - 574
  • [9] Ex vivo disease modelling of Rett syndrome: the transcriptomic and metabolomic implications of direct neuronal conversion
    Karaosmanoglu, Beren
    Imren, Gozde
    Ozisin, M. Samil
    Recber, Tuba
    Kiper, Pelin Ozlem Simsek
    Haliloglu, Goknur
    Alikasifoglu, Mehmet
    Nemutlu, Emirhan
    Taskiran, Ekim Z.
    Utine, Gulen Eda
    MOLECULAR BIOLOGY REPORTS, 2024, 51 (01)
  • [10] Abnormal olfactory receptor neuronal development in Rett syndrome
    Naidu, S
    Leopold, DA
    Ronnett, GV
    ANNALS OF NEUROLOGY, 1997, 42 (03) : P52 - P52